期刊文献+

中国2005年预防接种副反应试点监测数据分析 被引量:34

Data Analysis of National Pilot Surveillance of Adverse Events Following Immunization
原文传递
导出
摘要 目的对中国2005年预防接种副反应(AEFI)监测试点系统的运转情况进行分析和评价。方法描述性流行病学分析。结果中国2005年AEFI监测试点系统共报告AEFI 1 454例,病例来自10个试点省(自治区、直辖市),10个省AEFI报告的县(区、市)总覆盖率为41.3%。可供分析的1 303例AEFI中,疫苗反应占79.7%,偶合症占10.3%,实施差错占0.7%,注射反应占0.8%,不明原因占2.9%,待定占5.6%。在可供分析的全部1 038例疫苗反应中,最常见的分别为发热(29.2%)、注射部位脓肿(25.7%)和不伴过敏性休克的过敏反应(21.8%)。结论自建立AEFI监测试点系统后,监测系统的各项指标正在逐步得到完善。由于采用了统一的AEFI分类及病例定义,报告的数据可以进行汇总分析,以便及时发现疫苗使用管理中存在的问题。 Objective To know about the running of national AEFI pilot surveillance system. Methods Descriptive analysis method. Results The total reported AEFI cases of 10 pilot provinces in the year of 2005 are 1454 and 41.3% of the total counties in 10 provinces reported AEFI. The total reported AEFI were classified into vaccine reaction, coincidental, program error, injection reaction, unknown and pending cases, and accounted for 79.3%, 10. 3%, 0. 7%, 0. 8%, 2.9 %, and 5.6 %, respectively. Among vaccine reaction reported, the most common events was fever (29.2%) ,injection site abscess (25.7%) and other allergic reaction (21.8%). Conclusion Since the national AEFI pilot surveillance system has been established,the indicators of the surveillance system is being improved step by step. Benefiting from the introduction of the standardized AEFI classification and case definition,it is easy to collate and analyze the collected data from provinces, and the results would be helpful for timely detecting the problems during the process of vaccine handling and delivering.
出处 《中国计划免疫》 2007年第4期353-358,共6页 Chinese Journal of Vaccines and Immunization
关键词 预防接种副反应 监测 Adverse events following immunization Surveillance
  • 相关文献

参考文献4

  • 1WHO/WPRO. Immunization Safety Surveillance, Guidelines for Managers of Immunization Programmes on Reporting and Investigating Adverse Events Following Immunization[M].Manila: WHO/WPRO. 1999. 5-7.
  • 2郭飚.全球预防接种副反应监测系统的建立与发展[J].中国计划免疫,2005,11(3):229-233. 被引量:63
  • 3Weigong Z, Vitali P,John K I,et al. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS)-United States,1991-2001[J]. MMWR,2003,52(SS-1):1-24.
  • 4中国疾病预防控制中心.预防接种副反应监测试点工作指南[S].,2005..

二级参考文献9

  • 1留岚兰.浅谈培训效果的评估[J].技术经济与管理研究,2004(5):54-54. 被引量:31
  • 2谢广中.预防接种后不良反应分类之我见[J].中国计划免疫,2004,10(5):313-315. 被引量:13
  • 3WHO & WPRO. Immunization Safety Surveillance[M].Manila,Phillipines,1999.5~13.
  • 4PAHO.Guidelines for Managing Immunization Safety Concerns[M].Washington D C, United States, 2002.4.
  • 5Robert T Chen. AEFI Surveillance Systems in other Countries[R]. Beijing, China,2003.
  • 6Kari S Lankinen, Satu Pastila, Terhi Kilpi, et al. Vaccinovigilance in Europe-need for timeliness, standardization and resources[J]. Bull WHO.2004,82:828-835.
  • 7William L Atkinson, Charles (Skip) Wolfe. Epidemiology and Prevention of Vaccine Preventale Diseases Seventh Edition[M].2002.221-222.
  • 8Collet J P, MacDonald N, Cashman N, et al. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee[J]. Bull WHO, 2000,78:178-185.
  • 9马福宝,刁连东,汤奋扬.疫苗预防接种反应报告系统与报表分析[J].药物不良反应杂志,2004,6(1):14-17. 被引量:12

共引文献70

同被引文献125

引证文献34

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部